Capturing the anticipated/unanticipated consequences of COVID-19 (C19) and C19 prevention, management, and treatment strategies (C19PS) among Indigenous peoples (IP) in Arctic communities (AC)

  • Funded by Canadian Institutes of Health Research (CIHR)
  • Total publications:17 publications

Grant number: 172676

Grant search

Key facts

  • Disease

  • Start & end year

  • Known Financial Commitments (USD)

  • Funder

    Canadian Institutes of Health Research (CIHR)
  • Principle Investigator

  • Research Location

    Canada, Americas
  • Lead Research Institution

    University of Alberta Medicine
  • Research Category

    Policies for public health, disease control & community resilience

  • Research Subcategory

    Approaches to public health interventions

  • Special Interest Tags


  • Study Subject


  • Clinical Trial Details


  • Broad Policy Alignment


  • Age Group


  • Vulnerable Population

    Indigenous People

  • Occupations of Interest



The potential consequences of COVID-19 (C19) spreading in Northwest Territories (NT) and Nunavut (NU) remote and isolated communities are severe due to high rates of chronic conditions, overcrowded housing and limited health infrastructure. The Governments of NT and NU have implemented C19 prevention strategies (C19PS), such as travel bans and social distancing. There is an urgent need to capture and understand the anticipated and unanticipated consequences of C19, and C19PS, as well as on the treatment and management of patients in NT and NU, and gather culturally safe recommendations from and for the communities. In addition, we must document the challenges faced by healthcare professionals, public health and policymakers for future planning and mitigation. Working with 4 NT and 6 NU communities, leadership from Indigenous communities and groups, a Community Advisory Board including Elders, and the research team, this project will work with local community coordinators and local community research assistants to collect information via telephone interviews on the impacts of C19 and C19PS that can, upon analysis and dissemination, immediately be used in policy and planning for current and future pandemics. All data collection materials will be developed and led by communities and local staff will be hired to recruit and undertake the interviews, ensuring capacity building, local employment, and sustainability. The majority of the team are Indigenous and almost all have worked together on Indigenous Arctic projects. The team also includes NU/NT public health policymakers, specialists/experts (mental health, qualitative research, ethics/knowledge translation, C19 pandemic research) and international (USA, Finland, Greenland, and Russia) and national collaborators/ international advisory board members, and therefore results will be relevant for Arctic communities at the community, regional, territorial, national and international levels.

Publicationslinked via Europe PMC

Last Updated:39 minutes ago

View all publications at Europe PMC

Incidence and Determinants of Spontaneous Normalization of Subclinical Hypothyroidism in Older Adults.

Inadequate Reporting of Cointerventions, Other Methodological Factors, and Treatment Estimates in Cardiovascular Trials: A Meta-Epidemiological Study.

Prevalence and factors associated with chronic use of levothyroxine: A cohort study.

Challenges in the Management of Atrial Fibrillation With Subclinical Hyperthyroidism.

Incorporating Baseline Outcome Data in Individual Participant Data Meta-Analysis of Non-randomized Studies.

Levothyroxine Treatment and Cardiovascular Outcomes in Older People With Subclinical Hypothyroidism: Pooled Individual Results of Two Randomised Controlled Trials.

An individual participant data analysis of prospective cohort studies on the association between subclinical thyroid dysfunction and depressive symptoms.

Effect of Thyroid Hormone Therapy on Fatigability in Older Adults With Subclinical Hypothyroidism: A Nested Study Within a Randomized Placebo-Controlled Trial.

Low Reporting of Cointerventions in Recent Cardiovascular Clinical Trials: A Systematic Review.